Is Meniscal Volume Critical to Post-meniscectomy Symptoms?

NCT ID: NCT04647942

Last Updated: 2020-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With this study we would like to investigate whether a certain, critical loss of meniscal volume, is critical to the development of pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Background and rationale It is known that a partial meniscectomy of the knee is a risk factor to the development of early osteoarthritis with complaints of pain.
2. Trial objectives and Design 2.1 Trial objectives With this study we would like to investigate whether a certain, critical loss of meniscal volume, is critical to the development of pain.

2.2 Primary endpoints How much volume can be resected peroperatively without developing postoperative pain.

2.3 Secondary endpoints A possible correlation between the resected volume and the severity of the pain.
3. Selection and withdrawal of subjects

3.1 Inclusion criteria

* All patients who were treated with a partial meniscectomy for a meniscal tear and have postoperative MRI's.
* Age between 14 and 50 years old
* Women of child bearing age can be included: the study has no effect on their methods of contraception.

3.2 Exclusion criteria

* A history of a tibia plateau fracture or severe deformity of the knee
* Rupture of the ACL/PCL/collateral ligaments of the knee
* Focal cartilage defects of the knee

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meniscal Tear

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

meniscectomy volume pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meniscectomy

Patients who underwent a meniscectomy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who were treated with a partial meniscectomy for a meniscal tear and have postoperative MRI's.
* Age between 14 and 60 years old
* Women of child bearing age can be included: the study has no effect on their methods of contraception.

Exclusion Criteria

* A history of a tibia plateau fracture or severe deformity of the knee
* Rupture of the ACL/PCL/collateral ligaments of the knee
* Focal cartilage defects of the knee
Minimum Eligible Age

14 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johan Bellemans, MD, PhD

Role: STUDY_DIRECTOR

UZ Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals of Leuven

Leuven, Antwerp, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

V1 07112013

Identifier Type: -

Identifier Source: org_study_id